Funding
Turn ideas into impact
Show Me
Due: January 7, 2028
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-316
Due: January 7, 2028
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-346
Due: January 7, 2028
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-282
Due: January 7, 2028
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-318
Due: January 7, 2028
NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
Type
Grant
Source
Federal
Opp Number
PA-25-303
Due: January 7, 2028
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
US $375,000
Type
Grant
Source
Federal
Opp Number
PAR-25-298
Due: January 7, 2028
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
US $200,000
Type
Grant
Source
Federal
Opp Number
PAR-25-291
Due: January 7, 2028
Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-136
Due: January 7, 2028
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 – Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-024
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?